Casa di Cura La Maddalena, Divisione di Ematologia
About Casa di Cura La Maddalena, Divisione di Ematologia
"La Maddalena spa ha la sua sede sanitaria e amministrativa nel comune di Palermo. La Maddalena Spa è una delle realtà sanitarie private più conosciute e apprezzate sull’isola siciliana per la completezza dei suoi servizi e per le ottime prestazioni medico-sanitarie. La Maddalena Spa è una Casa di Cura di “alta specialità”, dispone di un dipartimento Oncologico di III Livello Medico Chirurgico, di un dipartimento Antalgico Ematoncologico con unità specializzate nel trapianto di midollo osseo e un dipartimento di Radioterapia Oncologica e di Microchirurgia Oculare. La Maddalena Spa offre una solida e attrezzata struttura diagnostica con TAC, PET e tomografia a emissioni di positroni e un qualificato laboratorio analisi e anatomia patologica."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Fondazione Italiana Linfomi ONLUS
4
Celgene
2
Hoffmann-La Roche
2
Clinical Trials at Casa di Cura La Maddalena, Divisione di Ematologia
During the past decade, Casa di Cura La Maddalena, Divisione di Ematologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
2008-08-21
2016-07-14
Completed
1,623
Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma
2005-12-01
2014-03-01
Unknown status
534
Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
2009-05-01
2011-05-01
Completed
1,927
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
2012-08-24
2016-09-16
Completed
572
Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission
2013-04-24
2023-12-31
Active, not recruiting
472
Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma
2012-02-01
2017-04-29
Completed
100
GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma
2015-08-25
2017-03-22
Terminated
34
Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN)
2019-09-02
2024-12-30
Active, not recruiting
299
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Casa di Cura La Maddalena, Divisione di Ematologia
According to Clinical.Site data, the most researched conditions in "Casa di Cura La Maddalena, Divisione di Ematologia" are
"Follicular Lymphoma" (2 trials), "B-Cell Lymphomas" (1 trials), "CD20 Positive Diffuse Large B-cell Lymphoma" (1 trials), "Elderly Unfit Patients" (1 trials) and "Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Casa di Cura La Maddalena, Divisione di Ematologia" in a lesser frequency.
Clinical Trials Intervention Types at Casa di Cura La Maddalena, Divisione di Ematologia
Most popular intervention types in "Casa di Cura La Maddalena, Divisione di Ematologia" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "CHOP" (1 trials), "Ga101" (1 trials), "Lenalidomide and low-dose dexamethasone" (1 trials), "Lenalidomide plus low-dose dexamethasone given for 18 four-week cycles" (1 trials) and "Melphalan, Prednisone and Thalidomide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Casa di Cura La Maddalena, Divisione di Ematologia
The vast majority of trials in "Casa di Cura La Maddalena, Divisione di Ematologia" are
8 trials for "All" genders.
Clinical Trials Status at Casa di Cura La Maddalena, Divisione di Ematologia
Currently, there are NaN active trials in "Casa di Cura La Maddalena, Divisione di Ematologia".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Casa di Cura La Maddalena, Divisione di Ematologia,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Casa di Cura La Maddalena, Divisione di Ematologia, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".